{"id":"W2031747016","doi":"10.1517/14712598.2014.922535","title":"Obinutuzumab for B-cell malignancies","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Chronic lymphocytic leukemia; Lymphoma; Oncology; Monoclonal antibody; Immunology; Internal medicine; Antibody; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006005261,0.0006327779,0.0009312521,0.001947232,0.0002108059,0.0008688792,0.0007553168,0.001120091,0.006617311],"category_scores_gemma":[0.0008083797,0.0001689027,0.0005245719,0.001823187,0.0003907156,0.001018552,0.0005882016,0.001588792,0.004020522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006691537,"about_ca_system_score_gemma":0.0009204202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008161134,"about_ca_topic_score_gemma":0.001123016,"domain_scores_codex":[0.9997537,0.00004937098,0.00002640356,0.00005577605,0.0000905623,0.00002415846],"domain_scores_gemma":[0.9996802,0.0001284965,0.00006382351,0.00001069699,0.00008590767,0.00003082852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006699442,0.00003202424,0.00009333483,0.01125016,0.00006869476,0.0001268001,0.00003830044,0.0001942455,0.0009784079,0.002257572,0.04156105,0.9433325],"study_design_scores_gemma":[0.000022132,0.00005371737,0.0003564918,0.004503976,0.00007065488,0.001004489,0.00001918209,0.00004557343,0.0002992051,0.001134803,0.9924818,0.000007989349],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008091188,0.9979163,0.00007861882,0.0003795451,0.0002569717,0.000004709658,0.00001971416,0.000006690028,0.001256424],"genre_scores_gemma":[0.0008694201,0.9971137,0.0001238851,0.0005061904,0.0003229662,0.00000804416,0.00005417862,0.000002269159,0.0009992244],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006617311,"threshold_uncertainty_score":0.02213711,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2552297063283639,"score_gpt":0.4601535520919414,"score_spread":0.2049238457635775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}